ELDN·28617K101·US·equity·Healthcare - Biotechnology-13D/G
ELDN (ELEDON PHARMACEUTICALS INC) is held by 58 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($13.5M), Ensign Peak Advisors, Inc ($7.6M), GEODE CAPITAL MANAGEMENT, LLC ($5.5M). Net institutional sentiment: Mixed.
See how ELDN's score breaks down across 4 SEC sources
Showing 1-20 of 67
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer